Niva Bupa Health Insurance Co Ltd (NSE:NIVABUPA)
₹ 80.73 -1.57 (-1.91%) Market Cap: 149.32 Bil Enterprise Value: 150.24 Bil PE Ratio: 42.49 PB Ratio: 4.78 GF Score: 12/100

Q1 2027 Niva Bupa Health Insurance Company Ltd Earnings Call Transcript

Jul 30, 2026 / 12:00PM GMT
Release Date Price: ₹85.92 (+0.21%)

Key Points

Positve
  • Niva Bupa Health Insurance Co Ltd (NSE:NIVABUPA) reported strong growth, with overall like-to-like growth of 23% and retail health growth of 35.5%, outpacing the industry.
  • Profit after tax improved to Rs 137.8 crores in Q1, with the combined insurance service ratio improving by 300 basis points to 100.2%.
  • The company's retail loss ratio improved by 90 basis points to 67.5%, driven by better underwriting and a focus on profitable segments.
  • Niva Bupa Health Insurance Co Ltd (NSE:NIVABUPA) achieved a top 50 ranking in 'Great Places to Work' and improved its NPS score to 62, reflecting strong customer and employee satisfaction.
  • The company's preferred provider network (PPN) strategy is yielding results, with 22% of claims closing in PPN hospitals, leading to 15-30% lower average claim sizes for like-to-like treatments.
  • The company maintains a healthy solvency ratio of 2.25, well above the regulatory minimum, and has an AAA issuer rating from ICRA.
Negative
  • Niva Bupa Health Insurance Co Ltd (NSE:NIVABUPA) experienced flat growth in the group business due to a challenging pricing environment, with the company choosing not to write large group accounts that do not meet underwriting philosophy.
  • The expense ratio increased by 90 basis points due to a mix change towards retail health, although this was offset by a reduction in loss ratio.
  • The company faces headwinds from the GST impact, which will continue to affect expense ratios until Q3, when results become comparable year-over-year.
  • The back book loss ratio remains elevated at around 75%, requiring annual price increases of high single digits to manage profitability.
  • The company's investment yield is relatively modest at 7.2%, and while it is increasing allocations to AIFs and ETFs, it remains conservative in its investment strategy.
  • The company's growth is partly dependent on sustaining a 8-10% growth premium over the market, which may be challenging given the competitive landscape and elevated base in the second half.
Operator

Ladies and gentlemen, good day and welcome to Q1 FY27 results of NEWA Bhupa Health Insurance Company Limited. Please note that any statements and comments made in today's call that may look like forward-looking statements are based on the information presently available to the management and do not constitute any indications of any future performance.

As future involves risks and uncertainties which could cause results to differ materially from the current view being expressed. (Operator Instructions)

Please note that this conference is being recorded.

I now hand the conference over to Mr. Anshuman.

Thank you. And over to you, sir.

Mr. Anshuman Mahendra Pareek
Niva Bupa Health Insurance Company Ltd - Director

Thanks, Atharoha.

Operator

Good evening, ladies and gentlemen.

Mr. Anshuman Mahendra Pareek
Niva Bupa Health Insurance Company Ltd - Director

We are extremely delighted to host the G1 FI27 results conference call of NIVA Bhupa Health

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot